BioLineRx Ltd. (TLV:BLRX)
Israel · Delayed Price · Currency is ILS · Price in ILA 1.500
-0.100 (-6.25%)
Jun 4, 2026, 11:50 AM IDT
BioLineRx Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -8.89 | -1.18 | -9.22 | -60.61 | -24.95 | -27.05 |
Depreciation & Amortization | 0.36 | 0.44 | 3.99 | 1.38 | 0.65 | 0.7 |
Other Amortization | 0.08 | 0.78 | 0.74 | - | 0.17 | - |
Loss (Gain) From Sale of Assets | 0.03 | 0.03 | - | - | - | - |
Asset Writedown & Restructuring Costs | - | - | 1.26 | 6.7 | - | - |
Stock-Based Compensation | 0.28 | 0.4 | 1.14 | 2.32 | 2.25 | 1.5 |
Other Operating Activities | -1.91 | -9.8 | -19.96 | 12.4 | -5.6 | 1.82 |
Change in Accounts Receivable | 1.47 | 2.43 | -2.12 | -0.36 | - | - |
Change in Inventory | 1.16 | 1 | -1.19 | -1.95 | - | - |
Change in Accounts Payable | 0.97 | -3.48 | -5.51 | 5.51 | 1.89 | -0.56 |
Change in Unearned Revenue | - | - | -12.96 | 12.96 | - | - |
Change in Other Net Operating Assets | -1.31 | 1.31 | -0.04 | -0.96 | -0.65 | 0.02 |
Operating Cash Flow | -7.76 | -8.07 | -43.87 | -22.61 | -26.24 | -23.57 |
Capital Expenditures | -0.03 | -0.03 | -0.05 | -0.12 | -0.13 | -0.1 |
Sale (Purchase) of Intangibles | -0 | -0 | -0 | -0.18 | -0.19 | - |
Investment in Securities | 2.37 | -8.52 | 29.43 | 1.74 | 4.32 | -38.13 |
Investing Cash Flow | 2.34 | -8.55 | 29.37 | 1.44 | 4.01 | -38.22 |
Long-Term Debt Issued | - | - | 19.22 | - | 9.13 | - |
Long-Term Debt Repaid | - | -5.01 | -14.94 | -1.99 | -3.05 | -3.57 |
Net Debt Issued (Repaid) | -4.94 | -5.01 | 4.28 | -1.99 | 6.07 | -3.57 |
Issuance of Common Stock | 3.2 | 13.89 | 16.38 | 17.04 | 14.36 | 61.32 |
Financing Cash Flow | -1.75 | 8.88 | 20.66 | 15.06 | 20.44 | 57.75 |
Foreign Exchange Rate Adjustments | 0.64 | 0.55 | 0.02 | -0.22 | -0.61 | 0.21 |
Net Cash Flow | -6.53 | -7.19 | 6.18 | -6.33 | -2.4 | -3.84 |
Free Cash Flow | -7.79 | -8.1 | -43.93 | -22.72 | -26.37 | -23.67 |
Free Cash Flow Margin | -555.92% | -686.36% | -151.78% | -473.42% | - | - |
Free Cash Flow Per Share | -0.00 | -0.00 | -0.04 | -0.02 | -0.03 | -0.04 |
Cash Interest Paid | 1.27 | 1.27 | 10.39 | 1.11 | 0.59 | 0.68 |
Levered Free Cash Flow | -5.37 | -3.88 | -43.89 | 2.33 | -15.32 | -14.54 |
Unlevered Free Cash Flow | -4.7 | -3.09 | -38.21 | 3.67 | -14.2 | -13.92 |
Change in Working Capital | 2.29 | 1.26 | -21.82 | 15.2 | 1.24 | -0.54 |